User login
- /content/poor-accrual-halts-one-five-cancer-clinical-trials
- /edermatologynews/article/80128/genitourinary-cancer/poor-accrual-halts-one-five-cancer-clinical
- /familypracticenews/article/80128/genitourinary-cancer/poor-accrual-halts-one-five-cancer-clinical
- /internalmedicinenews/article/80128/genitourinary-cancer/poor-accrual-halts-one-five-cancer-clinical
- /acssurgerynews/article/80128/genitourinary-cancer/poor-accrual-halts-one-five-cancer-clinical-trials
- /oncologypractice/article/80128/genitourinary-cancer/poor-accrual-halts-one-five-cancer-clinical
- /hematology-oncology/article/80128/genitourinary-cancer/poor-accrual-halts-one-five-cancer-clinical
- /internalmedicine/article/80128/genitourinary-cancer/poor-accrual-halts-one-five-cancer-clinical
- /dermatology/article/80128/genitourinary-cancer/poor-accrual-halts-one-five-cancer-clinical-trials
- /familymedicine/article/80128/genitourinary-cancer/poor-accrual-halts-one-five-cancer-clinical-trials
- /surgery/article/80128/genitourinary-cancer/poor-accrual-halts-one-five-cancer-clinical-trials